Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

22%

4 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed with results

Key Signals

3 with results86% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (7)
P 2 (2)
P 3 (1)
P 4 (3)

Trial Status

Completed6
Unknown6
Recruiting2
Terminated1
Not Yet Recruiting1
Active Not Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07018648Not ApplicableRecruiting

Clinical Safety and Efficacy Testing of a Medical Device Kardi Ai, an ECG Telemetry Monitoring System

NCT03418467Active Not Recruiting

Risk Factors in Tachycardiomyopathy

NCT06546046Not ApplicableNot Yet Recruiting

Analysis of the Efficacy and Stability of a Wearable ECG Monitor

NCT04617717RecruitingPrimary

Personalized Treatment for Patients With Premature Ventricular Beats

NCT04983797Not ApplicableCompleted

A Study Assessing Arrhythmia Mapping With the Multi-Electrode OPTRELL™ Mapping Catheter

NCT05087238Not ApplicableCompletedPrimary

CBT for Premature Ventricular Contractions

NCT04637230Unknown

Prevention of Stroke and Sudden Cardiac Death by Recording of 1-Channel Electrocardiograms

NCT04065893Completed

Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy

NCT02924285Phase 3Completed

Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease

NCT03340922Phase 4CompletedPrimary

MANual vs. automatIC Local Activation Time Annotation for Guiding Premature Ventricular Complex Ablation

NCT04186728Not ApplicableUnknownPrimary

Oral Magnesium Supplementation in Athletes With Premature Ventricular Contractions or Premature Atrial Contractions.

NCT02360397Phase 2CompletedPrimary

Ranolazine Mediated PVC Reduction in Ischemic Heart Disease

NCT01833455Phase 2TerminatedPrimary

Premature Ventricular Contractions (PVCs) and Blood Pressure Control

NCT03587558Phase 4UnknownPrimary

Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract

NCT03041519Not ApplicableUnknown

Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias

NCT00606736WithdrawnPrimary

Relativity Study Between Idiopathic Ventricular Arrhythmia and Sex Hormone Levels in Different Stages of Menstrual Cycle

NCT01566344Not ApplicableUnknown

Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes

NCT01780311Phase 4Unknown

Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias

Showing all 18 trials

Research Network

Activity Timeline